Drugmaker Warned for Lack of Product Testing

Drug Industry Daily
A A
The FDA issued a warning to an Oklahoma drug manufacturer after inspectors found significant GMP violations, including a lack of product testing.

To View This Article:

Login

Subscribe To Drug Industry Daily